Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

探索与服务
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
法律与隐私
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
  1. 首页
  2. 新闻
  3. STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

STAT News

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.

前往出版商网站继续阅读完整报道。

在 STAT News 阅读全文
S

作者 STAT News

7 September 2026|1 分钟阅读
分享
Health Tech
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
分享
← 返回 IE News

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

  • ‘Tactical athletes’ get new guidance for cardiovascular fitness

    STAT News

    ‘Tactical athletes’ get new guidance for cardiovascular fitness

    3 September 2026
  • STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and more

    STAT News

    STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and more

    3 September 2026
  • Opinion: Make infectious disease data boring again

    STAT News

    Opinion: Make infectious disease data boring again

    4 September 2026
  • STAT+: Seattle scientists launch $95 million AI biology effort

    STAT News

    STAT+: Seattle scientists launch $95 million AI biology effort

    3 September 2026
  • STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    STAT News

    STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    3 September 2026
  • STAT+: Recipients of gene-edited pig kidneys successfully receive human organs

    STAT News

    STAT+: Recipients of gene-edited pig kidneys successfully receive human organs

    3 September 2026

相关洞察

  • The Bio Revolution Is Here — And the World Is Already Choosing Sides

    Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.

    8 Sept 202613 min read
  • Quantum computing

    The race to master quantum computing could reshape medicine, energy and security.

    8 Sept 202623 min read
  • Workforce transformation and the future of skills

    10 cross-sector shifts creating the next business opportunities

    The biggest business opportunities of the next decade may not sit inside AI, energy, space, telecoms or manufacturing individually; they are emerging where growth in one sector creates a bottleneck—and therefore a market—in another.

    7 Sept 202610 min read
Browse all insights →

相关活动

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • Autonomous e-Mobility Forum 2026

    7 Sept 2026
    Qatar
  • 3rd Government Digital Transformation Summit

    7 Sept 2026
    Riyadh, Saudi Arabia
  • AeroTech Vietnam 2026

    8 Sept 2026
    Hanoi, Vietnam
浏览所有活动→

更多新闻中心内容

  • STAT+: Top Boston hospitals clash over Medicare Advantage network after split

    STAT+: Top Boston hospitals clash over Medicare Advantage network after split

    4 September 2026
  • Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more

    Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more

    5 September 2026
  • STAT+: OpenEvidence launches new family of AI models

    STAT+: OpenEvidence launches new family of AI models

    3 September 2026
  • STAT+: Fauci speaks, and writes

    STAT+: Fauci speaks, and writes

    3 September 2026
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

探索与服务
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
法律与隐私
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.